Syringes, Needles and Urinary Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

A syringe is a tube-like device used to intake and expel liquid. A needle is a very thin piece of tubular metal with a hollow interior. Needles are generally fitted with a plastic connector. A urinary catheter is a thin piece of flexible tubing that is used to collect urine from a patient into a drainage bag. GlobalData’s Medical Devices sector report, “Syringes, Needles and Urinary Catheters – Medical Devices Pipeline Product Landscape, 2021″ provides comprehensive information about the Syringes, Needles and Urinary Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Syringes, Needles and Urinary Catheters report provides key information and data related to:
Extensive coverage of the Syringes, Needles and Urinary Catheters under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Syringes, Needles and Urinary Catheters pipeline products.
Review of Recent Developments in the segment / industry
The Syringes, Needles and Urinary Catheters report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Syringes, Needles and Urinary Catheters under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Syringes, Needles and Urinary Catheters under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Syringes, Needles and Urinary Catheters and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Syringes, Needles and Urinary Catheters under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Aquabiliti
ARTE CORPORATION
Baxter International Inc
Bayer AG
Becton Dickinson and Co
Boston Children's Hospital
Cincinnati Children's Hospital Medical Center
C-Major Ltd
Daxor Corp
Difinity Solutions
Fernando Kerr Design
Galderma SA
Globe Medical Tech Inc (Inactive)
iScience Interventional Inc
Johns Hopkins University
Massachusetts Institute of Technology
Medigard Ltd
Minneapolis VA Medical Center
MonuMedical LLC
Neuroelectrics Barcelona SLU
NuvOx Pharma LLC
Olberon Medical Innovation SAS
Owen Mumford Ltd
Protectus Medical Devices, Inc.
Resultados y Calidad del Sistema Sanitario Publico de Andalucia
Rutgers The State University of New Jersey
Sharps Technology Inc
Silmag SA
Syrindicare, Inc
Telezon Ltd
Terumo Corp
U-Needle BV
Unilife Corporation
University of California Berkeley
University of California Irvine
University of Louisville
University of Massachusetts Amherst
University of South Florida
University of Texas Health Science Center at Houston
Virginia Commonwealth University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 10

2 Introduction 11

2.1 Syringes, Needles and Urinary Catheters Overview 11

3 Products under Development 12

3.1 Syringes, Needles and Urinary Catheters – Pipeline Products by Stage of Development 12

3.2 Syringes, Needles and Urinary Catheters – Pipeline Products by Segment 13

3.3 Syringes, Needles and Urinary Catheters – Pipeline Products by Territory 14

3.4 Syringes, Needles and Urinary Catheters – Pipeline Products by Regulatory Path 15

3.5 Syringes, Needles and Urinary Catheters – Pipeline Products by Estimated Approval Date 16

4 Syringes, Needles and Urinary Catheters – Pipeline Products under Development by Companies 17

4.1 Syringes, Needles and Urinary Catheters Companies – Pipeline Products by Stage of Development 17

4.2 Syringes, Needles and Urinary Catheters – Pipeline Products by Stage of Development 19

5 Syringes, Needles and Urinary Catheters Companies and Product Overview 21

5.1 Aquabiliti Company Overview 21

5.1.1 Aquabiliti Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 ARTE CORPORATION Company Overview 23

5.2.1 ARTE CORPORATION Pipeline Products & Ongoing Clinical Trials Overview 23

5.3 Baxter International Inc Company Overview 24

5.3.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.4 Bayer AG Company Overview 25

5.4.1 Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 Becton Dickinson and Co Company Overview 27

5.5.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Boston Children’s Hospital Company Overview 29

5.6.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 Cincinnati Children’s Hospital Medical Center Company Overview 30

5.7.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 C-Major Ltd Company Overview 32

5.8.1 C-Major Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 Daxor Corp Company Overview 33

5.9.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 33

5.10 Difinity Solutions Company Overview 34

5.10.1 Difinity Solutions Pipeline Products & Ongoing Clinical Trials Overview 34

5.11 Fernando Kerr Design Company Overview 35

5.11.1 Fernando Kerr Design Pipeline Products & Ongoing Clinical Trials Overview 35

5.12 Galderma SA Company Overview 36

5.12.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 36

5.13 Globe Medical Tech Inc (Inactive) Company Overview 37

5.13.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37

5.14 iScience Interventional Inc Company Overview 40

5.14.1 iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.15 Johns Hopkins University Company Overview 41

5.15.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 41

5.16 Massachusetts Institute of Technology Company Overview 42

5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 42

5.17 Medigard Ltd Company Overview 43

5.17.1 Medigard Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.18 Minneapolis VA Medical Center Company Overview 46

5.18.1 Minneapolis VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 46

5.19 MonuMedical LLC Company Overview 47

5.19.1 MonuMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 47

5.20 Neuroelectrics Barcelona SLU Company Overview 48

5.20.1 Neuroelectrics Barcelona SLU Pipeline Products & Ongoing Clinical Trials Overview 48

5.21 NuvOx Pharma LLC Company Overview 49

5.21.1 NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 49

5.22 Olberon Medical Innovation SAS Company Overview 50

5.22.1 Olberon Medical Innovation SAS Pipeline Products & Ongoing Clinical Trials Overview 50

5.23 Owen Mumford Ltd Company Overview 51

5.23.1 Owen Mumford Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.24 Protectus Medical Devices, Inc. Company Overview 52

5.24.1 Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52

5.25 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 53

5.25.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 53

5.26 Rutgers The State University of New Jersey Company Overview 54

5.26.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 54

5.27 Sharps Technology Inc Company Overview 55

5.27.1 Sharps Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.28 Silmag SA Company Overview 56

5.28.1 Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 56

5.29 Syrindicare, Inc Company Overview 57

5.29.1 Syrindicare, Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.30 Telezon Ltd Company Overview 58

5.30.1 Telezon Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

5.31 Terumo Corp Company Overview 60

5.31.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 60

5.32 U-Needle BV Company Overview 62

5.32.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 62

5.33 Unilife Corporation Company Overview 64

5.33.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 64

5.34 University of California Berkeley Company Overview 69

5.34.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 69

5.35 University of California Irvine Company Overview 70

5.35.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 70

5.36 University of Louisville Company Overview 71

5.36.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 71

5.37 University of Massachusetts Amherst Company Overview 72

5.37.1 University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 72

5.38 University of South Florida Company Overview 73

5.38.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 73

5.39 University of Texas Health Science Center at Houston Company Overview 74

5.39.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 74

5.40 Virginia Commonwealth University Company Overview 75

5.40.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 75

6 Syringes, Needles and Urinary Catheters- Recent Developments 76

6.1 Oct 07, 2021: BD unveils Nebraska-based manufacturing capacity to support U.S. vaccination agility and preparedness 76

6.2 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021 77

6.3 Sep 22, 2021: BD completes study investigating performance of glass prefillable syringes (PFS) in deep cold storage 77

6.4 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021 78

6.5 Sep 09, 2021: Gerresheimer extends contract with CFO Dr. Bernd Metzner ahead of schedule by a further five years 78

6.6 Sep 07, 2021: Daxor to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference 78

6.7 Sep 01, 2021: Shandong Weigao Group Medical Polymer Notice of Extraordinary General Meeting and Proposed Interim Dividend 79

6.8 Aug 27, 2021: Shandong Weigao Group Medical Polymer Announcement of Interim Results for the Six Months Ended 30 June 2021 79

6.9 Aug 27, 2021: Shandong Weigao Group Announces Interim Results for the Six Months Ended 30 June 2021 79

6.10 Aug 19, 2021: Dan Berish Joins Precision Medical Products as New President of Acute Care Division 79

6.11 Aug 05, 2021: Cardinal Health reports fourth quarter and full year results for fiscal year 2021 80

6.12 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021 82

6.13 Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021 82

6.14 Aug 03, 2021: Zimmer Biomet Announces Second Quarter 2021 Financial Results 82

6.15 Jul 29, 2021: West Announces Second-Quarter 2021 Results 83

6.16 Jul 29, 2021: BD to Present at UBS Genomics

2.0 and MedTech Innovations Summit 86

6.17 Jul 29, 2021: Poly Medicure announce Unaudited Quarterly Financial Results(Standalone & Consolidated) For The Quarter Ended

30.06.2021 86

6.18 Jul 29, 2021: Poly Medicure Announces Un-Audited Financial Results for the First Quarter ended on 30th June 2021 87

6.19 Jul 28, 2021: CONMED Announces financial results for the second quarter ended June 30, 2021 87

6.20 Jul 15, 2021: West to Host Second-Quarter 2021 Conference Call 91

6.21 Jul 13, 2021: Gerresheimer Q2 Net Profit Slightly Down Revenues Rise Sees Strong H2 Backs FY21 91

6.22 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 91

6.23 Jul 07, 2021: Adventa Announces Retirement of Independent and Non Executive Director 91

6.24 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer 91

6.25 Jun 21, 2021: Raaj Medisafe India Announces Audited Financial Results For The Year Ended March 31, 2021 92

6.26 Jun 17, 2021: Albert David Announces Statement of Standalone Audited Results for the Quarter and Year Ended 31st March 2021 92

6.27 May 28, 2021: Daxor to Present at the Summer Solstice – Best Ideas from the Buy Side Conference on June 2, 2021 92

6.28 May 28, 2021: Adventa announces quarterly report on consolidated results for the financial period ended 31 March 2021 93

6.29 May 27, 2021: MTD Group takes part in the global effort to accelerate the COVID-19 vaccination, thanks to its new Low Dead Space syringes 93

6.30 May 26, 2021: Samsung importing 1 mn LDS syringes to support Covid vaccination drive 93

6.31 May 17, 2021: Retractable Technologies Reports $23.4 Million in Operating Income for First Quarter Of 2021 93

6.32 May 13, 2021: Daxor Announces 61% Increase in Q1 2021 Sales Revenue 94

6.33 May 06, 2021: Cardinal Health reports third-quarter results for fiscal year 2021 95

6.34 May 05, 2021: West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference 96

6.35 Apr 28, 2021: Report from Annual General Meeting of Vitrolife AB (publ) 96

6.36 Apr 28, 2021: CONMED Announces First Quarter Financial Results 97

6.37 Apr 27, 2021: Shandong Weigao Group Medical Polymer notice of annual general meeting 98

6.38 Apr 27, 2021: Analytica announces expansion of Enhanced Infusion System into Middle East 99

6.39 Apr 15, 2021: West to Host First-Quarter 2021 Conference Call 100

6.40 Apr 06, 2021: Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2021 Financial Results 100

6.41 Apr 05, 2021: BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021 101

6.42 Apr 01, 2021: CONMED to Announce First Quarter 2021 Financial Results on April 28, 2021 101

6.43 Mar 31, 2021: Zimmer Biomet Announces Key Updates to Company’s Executive Leadership Team 101

6.44 Mar 31, 2021: Terumo begins production of “FN syringe” syringe for drug administration 102

6.45 Mar 30, 2021: Shandong Weigao Group Medical Polymer Announces Annual Results for the Year Ended 31 December 2020 102

6.46 Mar 30, 2021: Shandong Weigao Appointment And Resignation Of Directors, Re-Election of Retiring Independent Non-Executive Directors and Change Of Chairman Of The Board, CEO 103

6.47 Mar 29, 2021: Medoject sterile hypodermic and blunt fill needles manufactured by Chirana T. Injecta – discontinue use 104

6.48 Mar 29, 2021: Merit Medical Reports Results for Quarter Ended March 31, 2021 105

6.49 Mar 24, 2021: Notice of Annual General Meeting of Vitrolife 106

6.50 Mar 23, 2021: CONMED Announces Annual Meeting of Stockholders 107

6.51 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems 107

6.52 Mar 19, 2021: Zimmer Biomet expands role for Ivan Tornos appointing him to new COO 107

6.53 Mar 08, 2021: iRemedy procures supply of 500 million more low-dead space syringes and needles in support of “Project Vaccinate” 108

6.54 Mar 08, 2021: Shandong Weigao Group Medical Polymer announces POLL RESULTS FOR THE EXTRAORDINARY GENERAL MEETING HELD ON 8 MARCH 2021 109

6.55 Mar 04, 2021: Daxor to Present at the H.C. Wainwright Global Life Sciences Conference 109

6.56 Mar 03, 2021: PrecisionOS to showcase collaboration with Zimmer Biomet 109

6.57 Feb 26, 2021: Daxor Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020 110

6.58 Feb 26, 2021: Adventa announce Quarterly report on consolidated results for the financial period ended 31/12/2020 111

6.59 Feb 25, 2021: Japan Health System improves patient safety with adoption of NRFit Neuraxial Connectors, GEDSA announces 111

6.60 Feb 24, 2021: Milestone Scientific announces breakthrough CompuPulse system and receives notice of allowance for U.S. patent 112

6.61 Feb 23, 2021: Will Weatherford elected vice chair of the USF Board of Trustees 112

6.62 Feb 18, 2021: Zimmer Biomet to Present at the Cowen 41st Annual Health Care Conference 112

6.63 Feb 17, 2021: iRemedy’s “Project Vaccinate” program is gaining traction in 2021 with over 130 million needles and syringes delivered 113

6.64 Feb 17, 2021: St. Petersburg Conference on World Affairs to provide global perspective and insight into historic turmoil 113

6.65 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences 114

6.66 Feb 16, 2021: Vafa Jamali Appointed as CEO of “NewCo”, New Publicly Traded Spine and Dental Company to Spin Out of Zimmer Biomet 115

6.67 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 115

6.68 Feb 16, 2021: CONMED Corporation to Participate in a Virtual Fireside Chat at the SVB Leerink Global Healthcare Conference 116

6.69 Feb 12, 2021: Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021 116

6.70 Feb 12, 2021: BD to Present at Upcoming Investor Conferences 116

6.71 Feb 10, 2021: Zimmer Biomet to Present at Citi’s 2021 Healthcare Services, Medtech, Tools, and HCIT Virtual Conference 116

6.72 Feb 10, 2021: Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference 117

6.73 Feb 10, 2021: Vitrolife AB ADR reports Q4 results 117

6.74 Feb 09, 2021: PharmaJet Announces Appointment of Marian Wentworth to Board of Directors 117

6.75 Feb 05, 2021: Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021 117

6.76 Feb 04, 2021: Cardinal Health Earnings Preview 118

6.77 Feb 04, 2021: Terumo announce Financial Statements 119

6.78 Feb 03, 2021: Spectra Medical Devices introduces their new and convenient E-commerce site for health care providers worldwide 119

6.79 Jan 22, 2021: Conference call Report on Operations 2020 Vitrolife 119

6.80 Jan 07, 2021: Merit Medical to Participate in Two Upcoming Investor Conferences 120

6.81 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience 121

6.82 Dec 16, 2020: BD surpasses 1 billion injection device orders in support of COVID-19 vaccination efforts around the world 121

6.83 Dec 16, 2020: Successful Pilot integrates PrEP and Syringe Exchange Services 122

6.84 Dec 09, 2020: West Announces First-Quarter 2021 Dividend, 2021 Share Repurchase Program and Participation in Upcoming Investor Conference 123

6.85 Nov 30, 2020: On track to produce

177.6 million auto-disable syringes for government by March: HMD 123

7 Appendix 124

7.1 Methodology 124

7.2 About GlobalData 127

7.3 Contact Us 127

Table

Syringes, Needles and Urinary Catheters – Pipeline Products by Stage of Development 12

Syringes, Needles and Urinary Catheters – Pipeline Products by Segment 13

Syringes, Needles and Urinary Catheters – Pipeline Products by Territory 14

Syringes, Needles and Urinary Catheters – Pipeline Products by Regulatory Path 15

Syringes, Needles and Urinary Catheters – Pipeline Products by Estimated Approval Date 16

Syringes, Needles and Urinary Catheters Companies – Pipeline Products by Stage of Development 17

Syringes, Needles and Urinary Catheters – Pipeline Products by Stage of Development 19

Aquabiliti Pipeline Products & Ongoing Clinical Trials Overview 21

Aquastat SFR 20 mL Pre-Filled Flush Syringe – Product Status 21

Aquastat SFR 20 mL Pre-Filled Flush Syringe – Product Description 21

Aquastat SFR 5 mL Pre-Filled Flush Syringe – Product Status 22

Aquastat SFR 5 mL Pre-Filled Flush Syringe – Product Description 22

ARTE CORPORATION Pipeline Products & Ongoing Clinical Trials Overview 23

Lyophilized Dual Chamber Prefillable Syringe – Product Status 23

Lyophilized Dual Chamber Prefillable Syringe – Product Description 23

Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 24

ENFit Enteral Syringe – Product Status 24

ENFit Enteral Syringe – Product Description 24

Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 25

Picleo – Product Status 25

Picleo – Product Description 25

Plairvay – Product Status 26

Plairvay – Product Description 26

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 27

EFFIVAX – Product Status 27

EFFIVAX – Product Description 27

Smart Pen Needle – Product Status 28

Smart Pen Needle – Product Description 28

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 29

Magnet Needle – Product Status 29

Magnet Needle – Product Description 29

Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 30

Blood Specimen Collection Syringe – Product Status 30

Blood Specimen Collection Syringe – Product Description 30

Pre-Filled Syringe With Flush – Product Status 31

Pre-Filled Syringe With Flush – Product Description 31

C-Major Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

DUET – Product Status 32

DUET – Product Description 32

Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 33

Max-200 – Product Status 33

Max-200 – Product Description 33

Difinity Solutions Pipeline Products & Ongoing Clinical Trials Overview 34

NeedSwitch – Product Status 34

NeedSwitch – Product Description 34

Fernando Kerr Design Pipeline Products & Ongoing Clinical Trials Overview 35

FKD Safety Needle Tip – Product Status 35

FKD Safety Needle Tip – Product Description 35

Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 36

Restylane Syringe – Product Status 36

Restylane Syringe – Product Description 36

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37

Dual Chamber Safety Prefillable Syringe – Product Status 37

Dual Chamber Safety Prefillable Syringe – Product Description 37

Safety Butterfly Needle – Product Status 38

Safety Butterfly Needle – Product Description 38

Single Chamber Safety Prefillable Syringe – Product Status 38

Single Chamber Safety Prefillable Syringe – Product Description 39

iScience Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 40

iScience Smart Needle – Product Status 40

iScience Smart Needle – Product Description 40

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 41

Hybrid Needle System – Product Status 41

Hybrid Needle System – Product Description 41

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 42

Subcutaneous Injection Syringe – Product Status 42

Subcutaneous Injection Syringe – Product Description 42

Medigard Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

Manual Retractable Syringe – 3ml – Product Status 43

Manual Retractable Syringe – 3ml – Product Description 43

Manual Retractable Syringe – 5ml – Product Status 44

Manual Retractable Syringe – 5ml – Product Description 44

Pre-Filled Auto Retract Syringe – Product Status 44

Pre-Filled Auto Retract Syringe – Product Description 45

Minneapolis VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 46

Urinary Catheter – Product Status 46

Urinary Catheter – Product Description 46

MonuMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 47

DoubleDrive Syringe – Product Status 47

DoubleDrive Syringe – Product Description 47

Neuroelectrics Barcelona SLU Pipeline Products & Ongoing Clinical Trials Overview 48

Curved Syringe – Product Status 48

Curved Syringe – Product Description 48

NuvOx Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Syringe Sonication Device – Product Status 49

Syringe Sonication Device – Product Description 49

Olberon Medical Innovation SAS Pipeline Products & Ongoing Clinical Trials Overview 50

Intelliderm – Product Status 50

Intelliderm – Product Description 50

Owen Mumford Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

UniSafe Connected Auto-injector – Product Status 51

UniSafe Connected Auto-injector – Product Description 51

Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52

Safety Dental Syringe – Product Status 52

Safety Dental Syringe – Product Description 52

Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 53

Syringe – Product Status 53

Syringe – Product Description 53

Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 54

Jersey Safety Syringe – Product Status 54

Jersey Safety Syringe – Product Description 54

Sharps Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 55

Sharps Provensa – Product Status 55

Sharps Provensa – Product Description 55

Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 56

Peel Off Introducer (Standard/Silflash) – Product Status 56

Peel Off Introducer (Standard/Silflash) – Product Description 56

Syrindicare, Inc Pipeline Products & Ongoing Clinical Trials Overview 57

SYRINDICARE Syringe – Product Status 57

SYRINDICARE Syringe – Product Description 57

Telezon Ltd Pipeline Products & Ongoing Clinical Trials Overview 58

DuoDraw Transfer and Injection Device – Product Status 58

DuoDraw Transfer and Injection Device – Product Description 58

PolyDermic Plastic Hypodermic Needle – Product Status 59

PolyDermic Plastic Hypodermic Needle – Product Description 59

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 60

Fineglide – Product Status 60

Fineglide – Product Description 60

FN Syringe – Product Status 61

FN Syringe – Product Description 61

U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 62

Bella-mu 0.6 mm Intradermic Needle – Product Status 62

Bella-mu 0.6 mm Intradermic Needle – Product Description 62

Bella-mu 1.0 mm Intradermic Needle – Product Status 62

Bella-mu 1.0 mm Intradermic Needle – Product Description 63

Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 64

EZMix Engage – Product Status 64

EZMix Engage – Product Description 64

EZMix Genesis – Product Status 65

EZMix Genesis – Product Description 65

EZMix Prodigy – Product Status 65

EZMix Prodigy – Product Description 66

Unifill Finesse – Product Status 66

Unifill Finesse – Product Description 66

Unifill Select – Product Status 67

Unifill Select – Product Description 67

Unitract 3ml And 5ml With Luer Needle – Product Status 67

Unitract 3ml And 5ml With Luer Needle – Product Description 68

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 69

Microfabricated Microneedle – Product Status 69

Microfabricated Microneedle – Product Description 69

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 70

Painless Injection Device – Product Status 70

Painless Injection Device – Product Description 70

University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 71

Ergonomic Syringe – Product Status 71

Ergonomic Syringe – Product Description 71

University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 72

Syringe Needle Injection System – Product Status 72

Syringe Needle Injection System – Product Description 72

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 73

MicroNeedles – Product Status 73

MicroNeedles – Product Description 73

University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 74

Zeta Needle – Product Status 74

Zeta Needle – Product Description 74

Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 75

Dual-Vial Injection Device – Product Status 75

Dual-Vial Injection Device – Product Description 75

Figures

Syringes, Needles and Urinary Catheters – Pipeline Products by Stage of Development 12

Syringes, Needles and Urinary Catheters – Pipeline Products by Segment 13

Syringes, Needles and Urinary Catheters – Pipeline Products by Territory 14

Syringes, Needles and Urinary Catheters – Pipeline Products by Regulatory Path 15

Frequently asked questions

Syringes, Needles and Urinary Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Syringes, Needles and Urinary Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Syringes, Needles and Urinary Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Syringes, Needles and Urinary Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.